Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
American ginseng extract is a botanical drug derived from the roots of *Panax quinquefolius*, a medicinal plant indigenous to North America. Its primary bioactive constituents are ginsenosides, which are triterpenoid saponins categorized into protopanaxadiol (PPD) and protopanaxatriol (PPT) types. The extract is investigated for its diverse therapeutic potential, including the prevention of respiratory infections in immunocompromised patients, such as those with chronic lymphocytic leukemia (CLL), and the enhancement of cognitive performance and neuroprotection. Additionally, it has shown promise in preclinical models for the treatment of inflammatory bowel diseases like ulcerative colitis and the prevention of peptic ulcers. Its pharmacological effects are attributed to its ability to modulate immune responses, reduce oxidative stress, and provide gastrointestinal mucosal protection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on American ginseng extract.